Clinical trials for advancing innovative interventions for neurodegenerative diseases - European Commission
Funds early-stage clinical trials and research to develop and test innovative, multidisciplinary interventions for neurodegenerative diseases, emphasizing technology, data integration, and stakeholder engagement.
This grant is no longer accepting proposals
European Commission has archived this opportunity.
Funder: European Commission
Due Dates: April 13, 2027 (first-stage) | September 22, 2027 (second-stage)
Funding Amounts: ~€10,000,000 per project; total call budget €39,300,000; ~4 grants expected
Summary: Funds early-stage clinical trials and research to advance innovative interventions for neurodegenerative diseases, emphasizing multidisciplinary approaches, technology, and stakeholder engagement.
Description
This grant supports early-stage clinical trials and research projects focused on developing and testing innovative, multidisciplinary interventions for neurodegenerative diseases. The aim is to improve therapeutic effectiveness and patient quality of life through novel approaches that combine pharmacological and non-pharmacological strategies, leverage digital technologies (including AI and wearables), and promote broad stakeholder engagement. Projects are expected to generate robust evidence on safety and efficacy, investigate new mechanisms of action, and utilize or integrate existing data infrastructures. The program encourages collaboration, data sharing, and the involvement of social sciences and humanities to maximize societal impact and facilitate the adoption of new therapies.
